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Edited by Peter BrzezinskiAbstract The metal content of bovine NADH-Q oxidoreduc-
tase determined by inductively-coupled plasma atomic-emission
spectroscopy reveals the presence of about one atom of zinc
per molecule of ﬂavin mononucleotide. We applied Zn K-edge
extended X-ray absorption ﬁne structure spectroscopy (EXAFS)
to investigate the local structure of the bound zinc ion and to
identify the nature of the coordinating residues. The EXAFS
spectrum is consistent with a structured zinc binding site. By
combining information from ﬁrst-shell analysis and from metal-
loprotein data bases putative binding clusters have been built and
ﬁtted to the experimental spectrum using ab initio simulations.
The best ﬁtting binding cluster is formed by two histidine and
two cysteine residues arranged in a tetrahedral geometry.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Zinc binding site1. Introduction
The NADH-quinone oxidoreductase (complex I) plays a
central role in energy transduction, coupling electron transfer
from NADH to ubiquinone with proton pumping across the
inner mitochondrial membrane in eukaryotic organisms or
across the cytoplasmic membrane in prokariots. Mitochon-
drial complex I is one of the largest membrane-bound protein
assemblies, being formed by 14 central subunits and up to 32
accessory subunits, and including as cofactors a non-cova-
lently bound ﬂavin mononucleotide (FMN) molecule, two
binuclear and six tetranuclear iron–sulfur clusters [1,2].
Due to this high complexity, the information on its structure
and mechanism of action is still limited. Low resolution elec-
tron microscopy analyses [3–10] show that complex I is struc-
turally organized in two major domains: a membrane spanningAbbreviations: EXAFS, extended X-ray absorption ﬁne structure
spectroscopy; XRD, X-ray diﬀraction; ICP-AES, inductively-coupled
plasma atomic-emission spectroscopy; PVA, polyvinyl alcohol
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doi:10.1016/j.febslet.2007.11.019segment and a peripheral arm, which protrudes into the mito-
chondrial matrix (or the bacterial cytosol). Sazanov and
Hinchliﬀe reported the crystal structure of the hydrophilic
domain of complex I from the bacterium Thermus (T) thermo-
philus at 3.3 A˚ resolution [11]. Within this segment, the iron–
sulfur clusters are arranged in a ‘‘wire’’ that covers a distance
of 84 A˚, leading from the NADH oxidation site to the mem-
brane domain, where quinone reduction takes place.
The activity of complex I is inhibited at the level of the qui-
none site by a large number of compounds, being rotenone
the most commonly used [12]. The inhibitory eﬀect of divalent
cations on the catalytic activity has been reported. Within all
the metals tested, Zn2+ is the most eﬀective one [13]. Micromo-
lar concentrations of Zn2+ are known to inhibit the respiratory
chain [14] also at the level of complex III and complex IV
[15,16]. The inhibitory Zn binding site in complex III has been
identiﬁed by integrating X-ray diﬀraction (XRD) structural
information [17] with extended X-ray absorption spectroscopy
(EXAFS) [18]. Several Zn binding sites, characterized by a dif-
ferent aﬃnity, have been recently located by XRD in crystals of
the bovine cytochrome c oxidase [19]. In this enzyme EXAFS
analysis allowed us to deﬁne the coordinating residues and
the local structure of a high-aﬃnity inhibitory Zn site, puta-
tively located on the D-channel pathway [20]. In the bovine
cytochrome c oxidase, however, a constitutive, tightly bound,
Zn ion is also present. As a consequence, EXAFS analysis of
the inhibitory, exogenous Zn binding site, required a diﬀeren-
tial approach, in which Zn-protein complexes, characterized
by diﬀerent Zn/enzyme stoichiometries were examined [20].
In the present paper, we provide evidence that the bovine
complex I puriﬁed following standard procedures, also retains
a tightly bound Zn ion. By using EXAFS spectroscopy, we
determined its coordinating residues and local geometry,
which are typical of a costituive, endogenous metal site. Beside
its structural interest per se, the characterization of this site
opens the way to the study of additional inhibitory Zn binding
sites, which can now be carried out by using the diﬀerential
EXAFS approach already exploited in the case of bovine cyto-
chrome c oxidase.2. Materials and methods
NADH-quinone oxidoreductase was puriﬁed from bovine heart
mitochondria according to Hateﬁ [21]. The complex I concentrationblished by Elsevier B.V. All rights reserved.
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metrically after extraction of the cofactor from the complex by heating
in boiling water for 3 min and spinning down of the denatured pro-
teins. An oxidized–reduced extinction coeﬃcient of 9.8 mM1 cm1
at 450 nm was used. The metal content of diﬀerent preparations was
measured by inductively-coupled plasma atomic-emission spectros-
copy (ICP-AES) after resuspension in buﬀer TRIS 20 mM, dodecyl
maltoside 0.1%, pH 7.3 to FMN concentrations between 0.4 and
0.9 lM. The speciﬁc NADH-quinone oxidoreductase activity of our
preparations amounted to 3.0 ± 0.4 lmol NADH min1 mg1.
For EXAFS measurements the complex I suspensions were
supplemented with 2.5% w/v polyvinyl alcohol (PVA) (Fluka, Buchs,
Switzerland, Mw  130000) and dehydrated under N2 ﬂow. By this
procedure the enzyme is embedded at high concentration in dry
PVA ﬁlms, which have also the advantage of stability and ease of
handling [22].
EXAFS measurements were performed at the BM8 ‘‘GILDA’’
beam-line of the European Synchrotron Radiation Facility (ESRF)
in Grenoble using a Si(311) double crystal monochromator employing
dynamical sagittal focusing [23]. The photon ﬂux was of the order of
1010 photons per second and the spot size was 1 · 1 mm2. Data were
collected at room temperature using a 13-element hyper-pure Ge detec-
tor equipped with fast digital electronics with a peaking time equal to
1 ls. The analyzed spectrum was obtained from the average of three
scans for a total integration time of 60 s/point.
Data analysis was performed using the IFEFFIT code [24] as imple-
mented in the ATHENA and ARTEMIS packages [25] and adopting
the strategy described in [18]. Theoretical amplitude and phase shift
functions were calculated using the ab initio code FEFF 8.2 [26]. Scat-
tering potentials were calculated by overlapping the free atom densities
in the muﬃn tin approximation and then using the partially non-local
form for the exchange potentials within a self consistent ﬁeld.Fig. 1. (A) Experimental k3 weighted EXAFS function (continuous
line) obtained in a complex I sample characterized by a Zn/FMN
stoichiometry of 0.8 ± 0.2. The dotted line represents the calculated
best ﬁtting EXAFS function corresponding to a cluster formed by two
histidines and two cysteines. (B) Amplitude of the Fourier transform
(FT) of the k3 weighted EXAFS function.3. Results and discussion
Evaluation of the iron content in four independent enzyme
preparations by ICP-AES yielded Fe/FMN ratios varying
from 16 ± 2 to 20 ± 2. These values are in line with previous
estimates obtained in preparations puriﬁed according to the
same procedure, in which iron contents ranging from 15 to
19 iron atoms per FMN group were found [21]. From XRD
data of the hydrophilic arm of the complex [11], which con-
tains all the iron–sulfur centers, two binuclear Fe2S2 and six
tetranuclear Fe4S4 clusters have been identiﬁed for a total of
28 Fe atoms per complex. We have no unique explanation
for the systematically lower iron stoichiometry found by ana-
lytical methods in the isolated preparations; we can hypothe-
size that this discrepancy reﬂects the loss of one or more
subunits during the resuspension of the enzyme for ICP-AES
analysis or, more likely, a systematic underestimate of Fe by
ICP-AES in a complex characterized by a very high density
of Fe cofactors. Evaluation of the zinc content gave Zn/
FMN ratios ranging between 0.8 ± 0.2 and 1.3 ± 0.2 in four
diﬀerent preparations, indicating that the puriﬁed complex I
contains on average one stoichiometric zinc atom. Reduced–
oxidized spectra analysis shows that puriﬁed complex I con-
tains less than 0.2 nmol/mg protein of cytochromes (bc1 and
aa3) as previously reported (see also [21]). The speciﬁc activity
of our complex I samples (3.0 ± 0.4 lmol NADH min1 mg1)
well compares with the value of 4 lmol NADH min1 mg1
measured by Sharpley and Hirst on bovine complex I puriﬁed
with a diﬀerent protocol in the absence of exogenous divalent
cations [13]; this indicates that no inhibitory divalent cations
were present as contaminants in our preparations.
In order to asses the tightness of the stoichiometric Zn
binding to complex I, we exposed a fresh preparation of thecomplex to the action of Chelex resin for 20 h at 4 C in batch
mode (0.4 g resin in 10 ml of a 0.5 lM complex I suspension).
Following this treatment, the Fe/Zn ratio of the suspension
was tested by ICP-AES and compared with that of a non-
exposed control. A maximum 20% decrease was found upon
Chelex treatment, indicating a high-aﬃnity Zn binding site.
The presence of an endogenous, high-aﬃnity, Zn2+ binding
site in complex I is corroborated by the observation of a well
structured EXAFS signal, symptomatic of a highly ordered
local structure around the Zn atom. In Fig. 1 we show the
k3 weighted EXAFS function (panel A) and its Fourier trans-
form (panel B) obtained from a PVA-embedded complex I
sample characterized by a Zn/FMN ratio of 0.8 ± 0.2. In the
Fourier transform (Fig. 1B) we observe two clearly distinct
peaks centered at approximately 1.6 A˚ and 1.9 A˚ that, after
corrections for the phase factor, give a distance of about
2.0 A˚ and 2.3 A˚, respectively. When the contributions of more
distant atoms are considered, a triple peak in the 2.5–4.0 A˚
range appears, characteristic of histidine residue [27]. Inspec-
tion of Zn2+ target distances reported in datasets of high
quality protein crystal structures (metal coordination sites in
proteins, http://tanna.bch.ed.ac.uk/) shows typical Zn–O/N
Fig. 2. (A) Wireframe structure of the Zn2+ binding cluster best ﬁtting
the experimental XAFS data. (B) Sketch of the reference structural
units used in multi-shell multiple scattering analysis.
Table 1
Best ﬁtting structural parameters and parameterized ﬁrst-shell DW
factors for the Zn2+ binding cluster (see Fig. 2A)
Ligand
residue
Zn–Ne2 or Zn–Sc
distance (A˚)
Parameterized DW
factor (103 A˚2)
a or b angular
parameter ()
His1 2.00 (5) 3.2 121 (11)
His2 1.97 (4) 3.3 121 (11)
Cys1 2.27 (1) 3.6 88 (11)
Cys2 2.33 (1) 4.2 127 (6)
Angles are deﬁned as in Fig. 2B. The 1r error on the least-signiﬁcant
ﬁgure is given in brackets.
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tively. Such a diﬀerence is consistent with the markedly diﬀer-
ent radii of the O/N and S atoms, and agrees with the
separation of the two peaks detected in the FT.
First-shell analysis conﬁrms the presence of a mixture of
N/O and S atoms and a total coordination number of four.
Since the Zn–N/O and Zn–S EXAFS oscillations are nearly
out of phase, it is diﬃcult to determine the relative number
of sulfur and nitrogen scatterers from a ﬁrst-shell analysis, as
already observed by Clark-Baldwin et al. [28].
In order to associate each ﬁrst ligand with one or more ami-
no acid residues we make the following considerations. The
presence of sulfur points with high probability to cysteine res-
idues, because the methionine residue appears with a much
lower frequency, i.e. only two times (PDB entry code: 1qq9,
1b1b), in the full list of zinc coordination groups reported in
http://tanna.bch.ed.ac.uk/. The presence of N/O can be associ-
ated, in principle, with a number of aminoacid residues, i.e
His, Lys, Asp, Glu, Asn and Gln. However, the frequency re-
ported in the data bank strongly privileges the presence of His,
Asp and Glu and the FT of the experimental data show the
presence of at least one histidine residue. Moreover a large
number of ab initio simulations (not shown) indicate that,
when a carboxylate residue is inserted in a tetrahedral zinc
binding site, the corresponding amplitude of the FT of the sim-
ulated EXAFS should exhibit a prominent contribution in the
2.6–3.2 A˚ region which is not observed in the experimental
data. In view of the above arguments, we are left with three
main possibilities for the binding cluster: 1Cys 3His, 2Cys
2His and 3Cys 1His.
The three binding clusters were built in a tetrahedral geom-
etry [29] following the criteria described in [18]. For all the
clusters, histidine residues were built in Ne2 coordination
mode, being this conformation the most commonly found in
crystal structure [29]. Final ﬁtting was performed directly in
k space (with a k weight of 3), in the range 2.0–12.5 A˚1, using
all paths involving up to ﬁve scattering processes with an eﬀec-
tive path length 65 A˚. For each amino acid we have consid-
ered as degrees of freedom the distance of the ﬁrst neighbour
from zinc and an angular parameter (see Fig. 2B). As angular
parameters we chose: a bending angle for the His residues (b in
Fig. 2B, accounting for rotation of the imidazole ring around
an axis through the nitrogen bound to the metal, and perpen-
dicular to the imidazole plane) and the Zn–Sc–Cb angle of cys-
teine (a in Fig. 2B).
The Debye–Waller (DW) factors were parametrized with
analytical expressions of the form:
r2i ðDRi; T Þ ¼ r2i ðR0i; T Þ þ AiðT ÞDRi þ BiðT ÞDR2i
where T is the absolute temperature, R0i is the equilibrium dis-
tance for the atom found out by density functional theory
(DFT) calculations, DRi is the variation between the equilib-
rium and EXAFS calculated distance for atom i and
r2i ðR0i; T Þ, Ai(T), Bi(T) are third order polynomial functions
derived from DFT phonon normal modes calculations [30,31].
We found that the cluster which minimizes both the R factor
and the reduced-v2 is formed by two histidine and two cysteine
residues (see Fig. 2A). The correspondent best ﬁtting structural
and disorder parameters are reported in Table 1. When com-
paring the three models on the basis on the reduced-v2 statis-
tics [18] it appears that the best ﬁtting model is signiﬁcantly
better. In particular cluster 2His 2Cys is statistically betterthan 1His 3Cys within the conﬁdence interval of 2r and better
than cluster 3His 1Cys within 1r.
Tetrahedral zinc binding clusters formed by two histidine
and two cysteine residues are observed in a large number of
well structured protein regions, where the bridges formed be-
tween the metal ion and its coordinating residues contribute
signiﬁcantly to the stability of the protein.
It is a fact that no Zn2+ was seen in the high resolution struc-
ture of the water soluble part of T. thermophilus complex I.
The presence of an endogenous zinc site in the bovine structure
implies therefore that: (a) Zn binding residues, i.e. cysteine and
histidine, which are conserved in the bovine subunits are ab-
sent in the crystallized portion of T. thermophilus complex I
(subunits Nqo1–6 and Nqo9) and (b) the residues involved
in zinc binding are localized in subunits out of the seven crys-
tallized ones or in polypeptides not belonging to the fourteen
bacterial complex I central subunits.
We checked for conserved cysteine and histidine in the mam-
malian subunits (Box Taurus, Homo sapiens and Mus muscu-
lus) not present in the correspondent T. thermophilus
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ing residues are localized in all the seven proteins tested. Anal-
ogously, several conserved cysteine and histidine residues are
found in the other, not crystallized, central subunits. The
occurrence of these conserved residues is consistent with our
ﬁnding of a constitutive Zn binding site in the bovine complex,
not seen in the X-ray structure of the crystallized part of the T.
Thermophilus enzyme. In the absence of crystallographic infor-
mation, such a high number of putative zinc binding residues
makes impossible the localization of the metal site. We also no-
tice that all the histidine and cysteine residues of the accessory
subunits are in principle putative ligands.
In conclusion, our data indicate the presence in the bovine
complex I of one zinc binding site showing a coordination typ-
ical of endogenous, constitutive zinc ions playing a structural
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